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Abstract
Background: Acute myeloid leukemia is typically a disease of the older population and presents mostly in the fifth
decade of life. Myeloid sarcoma is a rare initial presentation of acute myeloid leukemia. Previously it has only been
documented in children and younger patients.
Case Presentation: We present an unusual case of retro-orbital myeloid sarcoma as an initial presentation of acute
myeloid leukemia in a 43-year-old Caucasian man, with rearrangement of chromosome 11q23 involving the MLL gene.
Conclusions: We present an unusual case of retro-orbital myeloid sarcoma as an initial presentation of acute myeloid
leukemia in a 43-year-old man, with rearrangement of chromosome 11q23 involving the MLL gene.
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Background
Acute myeloid leukemia (AML) is generally a disease of
older population with an average age of presentation of
66 years. It is uncommon before the age of 45 [1].
Several disorders preceding the onset of AML have
been reported. These include myelodysplastic syndrome
(MDS), myeloid dysplasia, aleukemic leukemia cutis,
hemophagocytic syndrome, and myeloid sarcoma (MS)
[2–6]. MS may be the first manifestation of AML, precede
it in presentation by months or years, or even present as
the initial manifestation of the relapse of a disease in
remission [7, 8]. It has been reported in 2–8 % of patients
with AML either as a single or as a multifocal tumor. MS
contains myeloblasts, with or without features of promye-
locytic or neutrophilic maturation. Frequently, MS dis-
plays myelomonocytic or pure monoblastic morphologic
features [8]. It may be present in variable locations, such
as skin, bone, lymph nodes, and very rarely in the retro-
orbital area [4, 7].
Case presentation
A 43-year-old Caucasian man presented to our emer-
gency room with frontal headache and blurred vision.
He had a recent history of surgically excised malignant
melanoma of the right cheek and right-sided Bells’ palsy
treated with acyclovir and steroids. His vital signs on ar-
rival were as follows: temperature 36.9 °C, blood pressure
129/79 mmHg, heart rate 68 beats per minute, respiratory
rate 18 breaths per minute, and arterial oxygen saturation
of 93 % on room air. A neurological examination revealed
weakness in adduction of his left eye with complete ptosis
(likely due to left third nerve palsy), ipsilateral conjunctival
injection and dilated pupil, a depressed nasolabial fold
on the left side, and drooping of the angle of his mouth
to the left with drooling (representing left seventh
nerve palsy). His deep tendon reflexes were decreased
to 1+ in his upper and lower extremities along with
generalized decreased sensation to pin prick and light
touch. Motor strength was preserved in all his extrem-
ities. The results of the rest of a physical examination
were within normal limits.
Blood work showed that our patient had a white blood
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g/dL, and platelet count of 268 × 103 /μL, all within
normal limits. His serum chemistry and results of a
chest X-ray were also normal. However, a computed
tomography (CT) scan of his head (Fig. 1) showed
broad-based multiple bilateral retro-orbital masses
along the medial side of the lateral rectus muscle, the
largest one measuring 10 mm. No abnormalities were
observed on magnetic resonance angiography or CT
angiography of his head. We started our patient on
vancomycin, ceftriaxone, and acyclovir while awaiting
lumbar puncture results. Infectious and autoimmune
analysis, including human immunodeficiency virus,
Lyme’s disease, cryptococcosis, coccidioidomycosis,
West Nile virus, California encephalitis, St Louis en-
cephalitis, eastern equine encephalitis, antinuclear anti-
bodies and antineutrophil cytoplasmic antibodies, had
negative results. A lumbar puncture showed clear fluid
with glucose 108 mg/dL, total protein 95 mg/dL, 1
WBC/mm3, and 1 red blood cell/mm3. No malignant
cells were seen in the cerebrospinal fluid.
Our patient complained of intractable headache and
was started on intravenous methylprednisolone 1 g/day,
which alleviated his symptoms. On day 8, a repeat CT
scan of his head showed no changes compared to previous
studies and our patient underwent a needle biopsy of the
left orbital mass. The biopsy results were inconclusive be-
cause only adipose tissue could be sampled, without any
evidence of malignant cells. A CT scan of his thorax and
abdomen was done owing to the high suspicious of malig-
nancy, and no signs of malignancy were appreciated. Our
patient was transferred to a specialized cancer center for
further evaluation, where he was treated with intravenous
immunoglobulins and plasmapheresis for suspected atyp-
ical Guillain-Barré syndrome presentation.
Two months later, our patient’s symptoms persisted
and he underwent another orbital biopsy that found
atypical lymphocytes. These lymphocytes stained posi-
tive with Leder stain, indicating their origin to be mye-
loid. The next day our patient developed fever; a
neurological examination showed no changes compared
to his previous admission. A repeated complete blood
count showed a WBC count of 1.1 × 103/μL [neutrophils
15 %, absolute neutrophil count (ANC) of 0.17 × 103/μL,
monocytes 19.8 %, lymphocytes 63 %], hemoglobin 7.7
g/dL, and a platelet count of 66 × 103/μL. Our patient
was started empirically on vancomycin, piperacillin-
tazobactam, and levofloxacin. A CT scan (Fig. 2) of his
head showed an increase in size of the orbital masses,
measuring 3.7 cm on the left and 2.7 cm on the right,
causing a mass effect on his optic nerves. Blood cultures
Fig. 1 Computed tomography scan of the head showing broad-based multiple bilateral retro-orbital masses along the medial side of the lateral
rectus muscle, the largest one measuring 10 mm
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remained negative for viral infections. On hospital day 8,
our patient’s neutropenia worsened, his complete blood
count showed a WBC count of 0.78 × 103/μL (neutrophils
9.4 % with ANC 0.07 × 103/μL, monocytes 40 %, lympho-
cytes 50 %), hemoglobin 7.4 g/dL, and a platelet count of
25 × 103/μL. A bone marrow biopsy was performed, which
showed 79 % blast cells with almost no myeloid maturation
present, consistent with AML. Flow-cytometry showed
immune-reactivity for stem cell markers CD34 and CD117,
a normal CD4 to CD8 ratio, and pan-T-cell antigens. A
cytogenetic study using florescent in situ hybridization
analysis revealed a rearrangement of chromosome 11q23
involving the MLL gene. The clinical course of this patient
was complicated by Clostridium difficile colitis. It was
decided to start the patient on induction chemotherapy
once his infective status improves. In the meantime, a
lower extremity ultrasound was done for his leg swelling
and showed bilateral distal lower extremity deep venous
thrombosis. Given our patient’s thrombocytopenia, an
inferior vena cava filter was placed to prevent pulmonary
embolism. On day 9, our patient developed ventricular
fibrillation, and died after a cardiac arrest.
Discussion
The National Cancer Institute estimated for 2015 a total
of 20,830 new cases of AML and 10,460 deaths due to
AML and associated complications in the USA [9]. MS
represents a particular form of AML in which a tumor-
like proliferation of blast cells occurs outside of the bone
marrow [10]. Previously, soft tissue accumulations of
leukemic cells were referred to as granulocytic sarcoma
(GS) or chloroma. These are rare localized extramedul-
lary tumor masses comprising myeloid precursor cells
[11]. A total of 87 % of GS biopsies were found to be
Leder stain-positive, indicating a myeloid origin of the
cells, as seen in our patient [12].
While several variants of AML have few or no cells of
granulocytic lineage, the broader term “myeloid sar-
coma” is currently preferred [13]. MSs are most com-
mon in certain subtypes of AML, particularly M5a
(monoblastic), M5b (monocytic), M4 (myelomonocytic),
and M2 (myeloblastic with maturation) [14]. Orbital GSs
have mostly been reported in African, Asian, South Pa-
cific, and Latin American children. They are extremely
rare in adult patients with AML [15]. MS may develop
de novo or concurrently with AML, myelo-proliferative
neoplasm (MPN), or MDS.
Cytogenetically, MS has been associated with a variety
of chromosomal abnormalities, including MLL gene re-
arrangement and t(8;21) translocation. It usually corre-
sponds to AML with a French-American-British (FAB)
classification of M4 or M5 [8, 16–19]. The presence of
Fig. 2 Computed tomography scan of the head showing increase in size of the orbital masses, measuring 3.7 cm on the left and 2.7 cm on the
right, causing a mass effect on the optic nerves
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retro-orbital masses preceding AML is rare. To the best
of our knowledge, since 1993 a total of 11 cases of GS
preceding AML in adults have been reported [10, 20–27],
most of them presenting with the cytogenic t(8:21) trans-
location and a fair prognosis. In the present report, we de-
scribe a very aggressive case of AML positive for CD34
and CD117 and a rearrangement of chromosome 11q23
involving the MLL gene that resulted in death. These
genetic abnormalities comprise a category of recurring
genetic abnormalities in the World Health Organization
classification. In a case series, the incidence of 11q23/MLL
rearrangement was found to be 2.8 % of almost 2,000
patients and was associated with poor outcome [28].
Interestingly, CD117, a transmembrane protein receptor
encoded by the c-kit proto-oncogene, initially viewed as a
primitive myeloid marker, was present in our patient.
CD117 has been identified in all FAB subtypes of AML
and approximately 4 % and has been associated with poor
outcomes [29].
Differential diagnoses in adults who present with simi-
lar symptoms are broad and require a high index of sus-
picion. Priego et al. recommend that the differential
diagnosis should include inflammatory/metabolic disease
(orbital inflammatory pseudo-tumor, thyroid orbitopathy,
sarcoidosis) and neoplasm (lacrimal tumors, lymphoma,
and metastasis) [30]. However, clinical behavior and re-
sponse to therapy do not seem to be influenced by age;
sex; anatomic site; de novo presentation or clinical history
related to AML, MDS, or MPN; histotype; phenotype; or
cytogenetic findings [4, 8].
Conclusion
MS, or GS, is an uncommon malignant neoplasm as-
sociated with AML. The presence of retro-orbital
masses preceding AML is rare and few cases have
been reported, most of them presenting with the
cytogenic t(8:21) translocation and a fair prognosis.
The present case is noteworthy because we describe a
very aggressive case of AML with rearrangement of
chromosome 11q23 involving the MLL gene that re-
sulted in death. The differential diagnosis for patients
of this age is broad and diagnosis can be challenging,
therefore a multidisciplinary approach and an appro-
priate clinical examination and history, accompanied
by a high index of suspicion, are needed for proper
diagnosis and treatment.
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